Published in Eur J Biochem on October 17, 1977
Regulation of intracellular glutathione levels in erythrocytes infected with chloroquine-sensitive and chloroquine-resistant Plasmodium falciparum. Biochem J (2002) 1.41
Amino acid sequence homology between pig heart lipoamide dehydrogenase and human erythrocyte glutathione reductase. Proc Natl Acad Sci U S A (1982) 1.11
Eosin B as a novel antimalarial agent for drug-resistant Plasmodium falciparum. Antimicrob Agents Chemother (2006) 0.90
Oxidative stress and psychological disorders. Curr Neuropharmacol (2014) 0.88
Molecular characterization and expression of Onchocerca volvulus glutathione reductase. Biochem J (1997) 0.77
DNA Damage in Major Psychiatric Diseases. Neurotox Res (2016) 0.75
Purification and characterization of glutathione reductase (E.C. 1.8.1.7) from bovine filarial worms Setaria cervi. J Parasit Dis (2012) 0.75
Protective effect of antioxidant rich aqueous curry leaf (Murraya koenigii) extract against gastro-toxic effects of piroxicam in male Wistar rats. Toxicol Rep (2014) 0.75
Human placenta thioredoxin reductase. Isolation of the selenoenzyme, steady state kinetics, and inhibition by therapeutic gold compounds. J Biol Chem (1998) 2.72
Substrate positions and induced-fit in crystalline adenylate kinase. J Mol Biol (1977) 2.69
Enzyme inactivation through sulfhydryl oxidation by physiologic NO-carriers. Nat Struct Biol (1998) 2.35
Thioredoxin reductase two modes of catalysis have evolved. Eur J Biochem (2000) 1.70
The thioredoxin system of the malaria parasite Plasmodium falciparum. Glutathione reduction revisited. J Biol Chem (2000) 1.63
Thioredoxin reductase as a pathophysiological factor and drug target. Eur J Biochem (2000) 1.63
Glutathione reductase from human erythrocytes. The sequences of the NADPH domain and of the interface domain. Eur J Biochem (1982) 1.63
The structure of the flavoenzyme glutathione reductase. Nature (1978) 1.61
The mechanism of thioredoxin reductase from human placenta is similar to the mechanisms of lipoamide dehydrogenase and glutathione reductase and is distinct from the mechanism of thioredoxin reductase from Escherichia coli. Proc Natl Acad Sci U S A (1997) 1.56
Synthetic inhibitors of adenylate kinases in the assays for ATPases and phosphokinases. Eur J Biochem (1975) 1.55
Topological comparison of adenyl kinase with other proteins. Nature (1974) 1.45
Three-dimensional structure of glutathione reductase at 2 A resolution. J Mol Biol (1981) 1.32
A hypothesis on the catalytic mechanism of the selenoenzyme thioredoxin reductase. Biochem J (1998) 1.23
The thioredoxin system of Plasmodium falciparum and other parasites. Cell Mol Life Sci (2002) 1.22
Trypanothione reductase from Trypanosoma cruzi. Purification and characterization of the crystalline enzyme. Eur J Biochem (1987) 1.21
Structural relationships in the adenylate kinase family. Eur J Biochem (1986) 1.18
[The particularities of contractile proteins of the arteries]. Biochem Z (1965) 1.18
FAD-binding site of glutathione reductase. J Mol Biol (1982) 1.18
Folding of the four domains and dimerization are impaired by the Gly446-->Glu exchange in human glutathione reductase. Implications for the design of antiparasitic drugs. Biochemistry (1993) 1.13
The enzymatic synthesis of thiophosphate analogs of nucleotides. Biochim Biophys Acta (1972) 1.11
Fluorescent and spin label probes of the environments of the sulfhydryl groups of porcine muscle adenylate kinase. J Biol Chem (1975) 1.07
Recombinant Plasmodium falciparum glutathione reductase is inhibited by the antimalarial dye methylene blue. FEBS Lett (1998) 1.07
Glutathione reductase of the malarial parasite Plasmodium falciparum: crystal structure and inhibitor development. J Mol Biol (2003) 1.05
Glutathione reductase and glutamate dehydrogenase of Plasmodium falciparum, the causative agent of tropical malaria. Eur J Biochem (1996) 0.99
Cloning and sequencing of mammalian glutathione reductase cDNA. Eur J Biochem (1990) 0.98
Redox processes in malaria and other parasitic diseases. Determination of intracellular glutathione. Histochemistry (1994) 0.97
Glutathione reductase from human erythrocytes: amino-acid sequence of the structurally known FAD-binding domain. Eur J Biochem (1981) 0.97
Trypanothione reductase from Trypanosoma cruzi. Catalytic properties of the enzyme and inhibition studies with trypanocidal compounds. Eur J Biochem (1989) 0.96
Glutathione reductase-deficient erythrocytes as host cells of malarial parasites. Biochem Pharmacol (1988) 0.94
A prodrug form of a Plasmodium falciparum glutathione reductase inhibitor conjugated with a 4-anilinoquinoline. J Med Chem (2001) 0.94
Deletion of the parasite-specific insertions and mutation of the catalytic triad in glutathione reductase from chloroquine-sensitive Plasmodium falciparum 3D7. Mol Biochem Parasitol (2000) 0.94
Glutathione reductase inhibitors as potential antimalarial drugs. Effects of nitrosoureas on Plasmodium falciparum in vitro. Biochem Pharmacol (1988) 0.94
The bacterial redox signaller pyocyanin as an antiplasmodial agent: comparisons with its thioanalog methylene blue. Redox Rep (2011) 0.91
Human thioredoxin reductase is efficiently inhibited by (2,2':6',2' '-terpyridine)platinum(II) complexes. Possible implications for a novel antitumor strategy. J Med Chem (2001) 0.90
Recombinant putative glutathione reductase of Plasmodium falciparum exhibits thioredoxin reductase activity. Mol Biochem Parasitol (1996) 0.90
Role of active site tyrosine residues in catalysis by human glutathione reductase. Biochemistry (1998) 0.89
Inhibition of human glutathione reductase by S-nitrosoglutathione. Eur J Biochem (1995) 0.89
Primary and tertiary structure of the principal human adenylate kinase. Eur J Biochem (1976) 0.88
Effects of antioxidants on glutathione levels and clinical recovery from the malnutrition syndrome kwashiorkor--a pilot study. Redox Rep (2005) 0.85
1,3-Bis(2-chloroethyl)-1-nitrosourea as thiol-carbamoylating agent in biological systems. Methods Enzymol (1995) 0.85
Generating compatible translation initiation regions for heterologous gene expression in Escherichia coli by exhaustive periShine-Dalgarno mutagenesis. Human glutathione reductase cDNA as a model. Nucleic Acids Res (1992) 0.85
Dinitrosyl-dithiol-iron complexes, nitric oxide (NO) carriers in vivo, as potent inhibitors of human glutathione reductase and glutathione-S-transferase. Biochem Pharmacol (1997) 0.85
Kinetic characterization of glutathione reductase from the malarial parasite Plasmodium falciparum. Comparison with the human enzyme. J Biol Chem (2000) 0.85
The structural isomerisation of human-muscle adenylate kinase as studied by 1H-nuclear magnetic resonance. Eur J Biochem (1982) 0.85
Inhibition of human glutathione reductase by 10-arylisoalloxazines: crystalline, kinetic, and electrochemical studies. J Med Chem (1996) 0.84
Mitochondrial adenylate kinase (AK2) from bovine heart. Homology with the cytosolic isoenzyme in the catalytic region. Eur J Biochem (1984) 0.84
The 58 kDa mouse selenoprotein is a BCNU-sensitive thioredoxin reductase. FEBS Lett (1997) 0.84
Denaturation and reactivation of dimeric human glutathione reductase--an assay for folding inhibitors. Eur J Biochem (1997) 0.84
Flavin analogs with antimalarial activity as glutathione reductase inhibitors. Biochem Pharmacol (1990) 0.83
NADPH-dependent disulphide reductases. Biochem Soc Trans (1989) 0.82
Halothane binds in the adenine-specific niche of crystalline adenylate kinase. FEBS Lett (1977) 0.82
Sensitivity of adenylate kinase isozymes from normal and dystrophic human muscle to sulfhydryl reagents. Biochim Biophys Acta (1972) 0.81
A glutathione reductase-like flavoenzyme of the malaria parasite Plasmodium falciparum: structural considerations based on the DNA sequence. Biochem Soc Trans (1996) 0.80
Glutathione and association antioxidant systems in protein energy malnutrition: results of a study in Nigeria. Free Radic Biol Med (1995) 0.80
Mitochondrial GTP-AMP phosphotransferase. 1. Purification and properties. Eur J Biochem (1979) 0.80
A method to determine the carbamoylating potential of 1-(2-chloroethyl)-1-nitrosoureas. IARC Sci Publ (1987) 0.79
Glutathione reductase from human erythrocytes. Amino-acid sequence of a major fragment that links the FAD, NADP and interface domains. Eur J Biochem (1979) 0.79
Muscle adenylate kinase in Duchenne muscular dystrophy. Biochim Biophys Acta (1986) 0.79
The C-terminal fragment of human glutathione reductase contains the postulated catalytic histidine. FEBS Lett (1979) 0.79
Glutathione reductase in human and murine lung tumors: high levels of mRNA and enzymatic activity. Cell Mol Biol (Noisy-le-grand) (1993) 0.78
Mitochondrial adenylate kinase (AK2) from bovine heart. The complete primary structure. Eur J Biochem (1986) 0.78
Studies on glutathione reductase and methemoglobin from human erythrocytes parasitized with Plasmodium falciparum. Mol Biochem Parasitol (1987) 0.78
Trypanothione and N1-glutathionylspermidine: isolation and determination. Methods Enzymol (1995) 0.78
Interaction of a glutathione S-conjugate with glutathione reductase. Kinetic and X-ray crystallographic studies. Eur J Biochem (1984) 0.77
[Extraction and purification of arterial actomycosin, actin and extra globulin]. Biochem Z (1965) 0.77
Inhibition of human glutathione reductase by the nitrosourea drugs 1,3-bis(2-chloroethyl)-1-nitrosourea and 1-(2-chloroethyl)-3-(2-hydroxyethyl)-1-nitrosourea. A crystallographic analysis. Eur J Biochem (1988) 0.77
Assembly and functional expression of murine glutathione reductase cDNA: a sequence missing in expressed sequence tag libraries. Biochim Biophys Acta (2000) 0.77
Molecular cloning and characterization of a putative glutathione reductase gene, the PfGR2 gene, from Plasmodium falciparum. Eur J Biochem (1996) 0.77
Properties of adenylate kinase after modification of Arg-97 by phenylglyoxal. Biochim Biophys Acta (1978) 0.77
Plasmodium falciparum glutathione reductase exhibits sequence similarities with the human host enzyme in the core structure but differs at the ligand-binding sites. Mol Biochem Parasitol (1995) 0.77
FAD analogues as prosthetic groups of human glutathione reductase. Properties of the modified enzyme species and comparisons with the active site structure. Eur J Biochem (1985) 0.76
Preparation and characterization of a crystalline human ATP:AMP phosphotransferase. Biochim Biophys Acta (1972) 0.76
Studies on the histidine residues of rabbit muscle myokinase. Biochim Biophys Acta (1970) 0.76
Protein-chemical standardization of the erythrocyte glutathione reductase activation test (EGRAC test). Application to hypothyroidism. Int J Vitam Nutr Res (1991) 0.76
Low resolution structure of human erythrocyte glutathione reductase. J Mol Biol (1977) 0.76
Human cytosolic adenylate kinase allelozymes; purification and characterization. Biochim Biophys Acta (1990) 0.75
No evidence for inhibition of human glutathione reductase by valproic acid. Biochem Pharmacol (1994) 0.75
On the geometry of leukocyte NADPH-oxidase, a membrane flavoenzyme. Inferences from the structure of glutathione reductase. FEBS Lett (1983) 0.75
Low resolution structure of adenylate kinase. J Mol Biol (1973) 0.75
Microinjected glutathione reductase crystals as indicators of the redox status in living cells. FEBS Lett (1999) 0.75
Flavins and flavoenzymes in diagnosis and therapy. Methods Mol Biol (1999) 0.75
Inogranic tripolyphosphate (PPPi) as substrate for crystalline adenylate kinases. Hoppe Seylers Z Physiol Chem (1972) 0.75
Antimalarial activity of the ethanol/alcohol oxidase system in vitro. Free Radic Res Commun (1990) 0.75
[Chronic lichenoid dermatitis in sensitization to alpha-amylase in a baker]. Z Hautkr (1987) 0.75
Photoinactivation of glutathione reductase by hematoporphyrin and Al-phthalocyanine tetrasulfonate. Biochem Soc Trans (1996) 0.75
Superotemporal coloboma of the iris, ciliary body, and choroid. Am J Ophthalmol (1988) 0.75
News and views on thioredoxin reductases. Redox Rep (1999) 0.75
Medical target prediction from genome sequence: combining different sequence analysis algorithms with expert knowledge and input from artificial intelligence approaches. Comput Chem (2001) 0.75
[Elimination and excretion of adenylate kinases following cell damage]. Klin Wochenschr (1975) 0.75